摘要
由中国抗癌协会肺癌专业委员会和广东省临床试验协会/中国胸部肿瘤研究协作组主办的“第20届中国肺癌高峰论坛”于2023年3月4日在广州顺利召开。此次论坛以非小细胞肺癌(non-small cell lung cancer,NSCLC)少见/罕见靶点为主题,从少见/罕见靶点的精准检测、新型临床研究与围术期治疗等角度开展相关学术探讨,并最终达成了专家共识。
作者
吴一龙
陆舜
程颖
周清
涂海燕
周清华
王绿化
张力
周建英
黄诚
陈明
胡成平
揣少坤
汪笑男
刘晓晴
刘基巍
周鹏辉
陈维之
严令华
刘云鹏
刘安文
张绪超
李慧
陈蓉蓉
林冬梅
谢聪颖
朱正飞
梁会营
宋勇
董晓荣
赵明芳
乔贵宾
崔久嵬
李子明
王志杰
陈晓媛
杨农
林根
田攀文
范云
宋启斌
陈元
段建春
王佳蕾
朱波
汪步海
赵军
于起涛
王立峰
张海波
胡洁
马锐
张同梅
林劼
褚倩
任胜祥
姚煜
邬麟
王慧娟
吴芳
钟文昭
胡毅
陈克能
赵健
张力
杨帆
王群
岳东升
周建娅
申鹏
张嘉涛
闫小龙
黄媚娟
冯卫能
李力
中国抗癌协会肺癌专业委员会
广东省临床试验协会/中国胸部肿瘤研究协作组
WU Yi-long;LU Shun;CHENG Ying;ZHOU Qing;TU Hai-yan;ZHOU Qing-hua;WANG LU-hua;ZHANG Li;ZHOU Jian-ying;HUANG Cheng;CHEN Ming;HU Cheng-ping;CHUAI Shao-kun;WANG Xiao-nan;LIU Xiao-qing;LIU Ji-wei;ZHOU Peng-hui;CHEN Wei-zhi;YAN Ling-hua;LIU Yun-peng;LIU An-wen;ZHANG Xu-chao;LI Hui;CHEN Rong-rong;LIN Dong-mei;XIE Cong-ying;ZHU Zheng-fei;LIANG Hui-ying;SONG Yong;DONG Xiao-rong;ZHAO Ming-fang;QIAO Gui-bin;CUI Jiu-wei;LI Zi-ming;WANG Zhi-jie;CHEN Xiao-yuan;YANG Nong;LIN Gen;TIAN Pan-wen;FAN Yun;SONG Qi-bin;CHEN Yuan;DUAN Jian-chun;WANG Jia-lei;ZHU Bo;WANG Bu-hai;ZHAO Jun;YU Qi-tao;WANG Li-feng;ZHANG Hai-bo;HU Jie;MA Rui;ZHANG Tong-mei;LIN Jie;CHU Qian;REN Sheng-xiang;YAO Yu;WU Lin;WANG Hui-juan;WU Fang;ZHONG Wen-zhao;HU Yi;CHEN Ke-neng;ZHAO Jian;ZHANG Li;YANG Fan;WANG Qun;YUE Dong-sheng;ZHOU Jian-ya;SHEN Peng;ZHANG Jia-tao;YAN Xiao-long;HUANG Mei-juan;FENG Wei-neng;LI Li;Chinese Association of Lung Cancer;Guangdong Association of Clinical Trials(GACT)/Chinese Thoracic Oncology Group(CTONG)(不详;Guangdong Lung Cancer Institute,Guangdong Provincial People's Hospital(Guangdong Academy of Medical Sciences),Southern Medical University,Guangzhou 510080,China;Shanghai Chest Hospital,Shanghai Jiaotong University,Shanghai 200030,China;Jilin Cancer Hospital,Changchun 130021,China;West China Hospital,Sichuan University,Chengdu 610041,China;Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center,Guangdong Shenzhen 518116,China;Sun Yat-sen University Cancer Center,Guangzhou 510060,China;The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310031,China;Fujian Cancer Hospital,Fuzhou 350011,China;Xiangya Hospital of Central South University,Changsha 410008,China;Burning Rock Biotech Co.,Ltd.,Guangzhou 510300,China;Nanjing Geneseeq Technology Inc.,Nanjing 210032,China;Chinese PLA General Hospital,Beijing 100071,China;The First Affiliated Hospital of Dalian Medical University,Liaoning Dalian 116011,China;Wuxi Genecast Biotechnology Co.,Ltd.,Jiangsu Wuxi 214105,China;Shanghai Tongshu Biotechnology Co.,Ltd.,Shanghai 200444,China;The First Hospital of China Medical University,Shenyang 110001,China;The Second Affiliated Hospital of Nanchang University,Nanchang 330006,China;Beijing GenePlus Technology Co.,Ltd.,Beijing 102206,China;Beijing Cancer Hospital,Beijing 100142,China;The 2nd Affiliated Hospital of Wenzhou Medical University,Zhejiang Wenzhou 325027,China;Fudan University Shanghai Cancer Center,Shanghai 200032,China;General Hospital of Eastern Theater Command,PLA,Nanjing 210002,China;Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;The First Bethune Hospital of Jilin University,Changchun 130021,China;Cancer Hospital,Chinese Academy of Medical Sciences,Beijing 100021,China;School of Medicine,Tsinghua University,Beijing 100084,China;Hunan Cancer Hospital,Changsha 410013,China;Cancer Hospital of the University of Chinese Academy of Sciences,Zhejiang Cancer Hospital,Hangzhou 310022,China;Cancer Center,Renmin Hospital of Wuhan University,Wuhan 430060,China;Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science&Technology,Wuhan 430030,China;Xinqiao Hospital,Army Medical University,Chongqing 400037,China;Subei People's Hospital Affiliated to Nanjing Medical University,Jiangsu Yangzhou 225001,China;Guangxi Medical University Cancer Hospital,Nanning 530012,China;Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China;Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120,China;Zhongshan Hospital,Fudan University,Shanghai 200032,China;Liaoning Cancer Hospital&Institute,Shenyang 110042,China;Beijing Chest Hospital,Capital Medical University,Beijing 101149,China;The Second Affiliated Hospital of Kunming Medical University,Kunming 650101,China;Shanghai Pulmonary Hospital,Tongji University,Shanghai 200433,China;First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China;He'nan Cancer Hospital,Affiliated Cancer Hospital of Zhengzhou University,Zhengzhou 450003,China;The Second Xiangya Hospital of Central South University,Changsha 410011,China;Affiliated Cancer Hospital and Institute of Guangzhou Medical University,Guangzhou 510095,China;Peking Union Medical College Hospital,Beijing 100032,China;Peking University People's Hospital,Beijing 100044,China;Tianjin Medical University Cancer Institute and Hospital,Tianjin 300060,China;Nanfang Hospital,Guangzhou 510515,China;Tangdu Hospital,Air Force Military Medical University,Xi'an 710038,China;The First People's Hospital of Foshan,Guangdong Foshan 528000,China;Daping Hospital of Army Medical University,Chongqing 400042,China)
出处
《循证医学》
2023年第3期129-139,共11页
The Journal of Evidence-Based Medicine
基金
国家自然科学基金面上项目(82072562)
广东省肺癌转化医学重点实验室项目(2017B030314120)
广东省医学领军人才配套科研项目(KJ012019426)。
关键词
非小细胞肺癌
少见/罕见靶点
共识
争鸣
non-small cell lung cancer
uncommon/rare mutations
consensus
contention
